Medical Devices & Consumables
Global Prelabor Rupture of Membranes PROM Rapid Tests Market Research Report 2026
- Nov 14, 26
- ID: 760884
- Pages: 128
- Figures: 137
- Views: 14
The global Prelabor Rupture of Membranes PROM Rapid Tests market was valued at US$ 124 million in 2025 and is anticipated to reach US$ 206 million by 2032, at a CAGR of 7.6% from 2026 to 2032.
Prelabor Rupture of Membranes PROM Rapid Tests are in vitro diagnostic products used to support rapid identification of fetal membrane rupture by detecting amniotic-fluid-associated biomarkers in vaginal or cervicovaginal specimens. The market primarily covers qualitative rapid tests targeting placental alpha-microglobulin-1 PAMG-1, insulin-like growth factor binding protein-1 IGFBP-1, and dual-biomarker combinations such as IGFBP-1 and alpha-fetoprotein AFP. Commercial products are predominantly based on lateral flow immunochromatography and are supplied in strip or cassette formats, while fluorescence immunoassay and reader-assisted systems represent an emerging technology route. Typical products combine a sterile collection swab, extraction solution and single-use detection device, with results generally available within approximately 5 to 15 minutes. The products are mainly used for Preterm PROM Testing and Term PROM Testing in labor and delivery departments, obstetric emergency assessment, obstetric outpatient settings and clinical laboratories. Current products range from highly sensitive PAMG-1 assays with thresholds around 5 ng/mL to IGFBP-1 assays with product-specific cut-offs, while dual-biomarker systems provide simultaneous detection of two amniotic-fluid-associated proteins.
Key Findings
IGFBP-1 Tests have the broadest confirmed manufacturing base among current product types
China Europe and the United States form the principal manufacturing centers in the confirmed supplier pool
Market Trends
The Prelabor Rupture of Membranes PROM Rapid Tests market is moving from conventional clinical observation and less specific biochemical methods toward more standardized amniotic-fluid biomarker testing in diagnostically uncertain cases. PAMG-1 and IGFBP-1 remain the principal single-biomarker routes, while dual-biomarker products combining IGFBP-1 and AFP provide an additional differentiation strategy. Product architecture is also evolving from visually interpreted strips toward cassette formats and reader-assisted testing. BIOSYNEX, for example, currently offers IGFBP-1 strip and cassette products as well as an IGFBP-1 and AFP dual-biomarker product that can be configured for automated reading. PAMG-1 products such as AmniSure continue to emphasize high analytical sensitivity and rapid bedside workflow, while the broader market is moving toward easier sampling, standardized interpretation and stronger resistance to potential specimen interference.
Market Dynamics
Drivers
Demand for Prelabor Rupture of Membranes PROM Rapid Tests is supported by the need to rapidly distinguish true membrane rupture from other causes of vaginal fluid leakage, because diagnostic uncertainty can affect observation, antimicrobial management, fetal monitoring and timing of delivery. Biomarker testing has an established role when symptoms suggest rupture but amniotic-fluid pooling is not directly observed during clinical examination. IGFBP-1 and PAMG-1 are incorporated into established diagnostic pathways for suspected preterm membrane rupture, providing a stable clinical foundation for test utilization. Expansion of point-of-care diagnostics, broader availability of rapid immunoassays and improving obstetric diagnostic capacity in emerging healthcare systems are further increasing the addressable testing population.
Restraints
Market penetration is structurally limited because biomarker testing is not required for every pregnancy or every patient presenting with suspected membrane rupture. When amniotic-fluid pooling is clearly observed, additional biochemical testing may not be required, reducing the theoretical testing rate relative to the overall number of PROM cases. Traditional examination, pH-based testing and microscopy also remain available in some institutions. In addition, the market has a wide price spectrum between premium international brands and lower-cost regional products, while the expanding supply base of Chinese lateral flow manufacturers is increasing price competition. As a result, volume growth does not necessarily translate into equivalent growth in average selling prices.
Opportunities
The strongest market opportunity lies in increasing adoption among symptomatic patients whose membrane status remains uncertain after initial clinical assessment rather than in universal screening. Secondary hospitals, regional maternity centers and obstetric outpatient settings in emerging markets remain underpenetrated relative to major tertiary institutions. Additional opportunities are developing around dual-biomarker detection, instrument-assisted interpretation, fluorescence immunoassay and integrated sampling formats that can reduce operator variability. Wider use of rapid tests in decentralized maternity care can also shorten diagnostic turnaround and support more consistent clinical pathways, particularly where access to specialized laboratory testing is limited.
Challenges
The industry faces persistent differences in clinical practice, reimbursement, hospital procurement and regulatory requirements between markets. Assays must maintain reliable performance in specimens potentially affected by blood, semen, urine, vaginal medication or infectious agents, making antibody selection, interference control and lot-to-lot reproducibility important technical barriers. Product positioning also requires clear separation between membrane-rupture diagnosis and adjacent applications such as preterm-birth risk assessment, as some biomarker families are used in both areas. Manufacturers therefore need to balance analytical performance, regulatory compliance and product affordability while facing increasing competition from large-scale lateral flow suppliers.
Industry Chain Analysis
The upstream industry chain includes monoclonal and polyclonal antibodies and other biological reagents targeting PAMG-1, IGFBP-1 and AFP, together with nitrocellulose membranes, sample pads, conjugate pads, colloidal gold, latex or fluorescent signal materials, extraction buffers, sterile swabs, plastic housings and packaging components. Biological reagents and antibody pairing have a disproportionate impact on sensitivity, specificity, interference resistance and batch consistency, while conventional membranes, plastic components and packaging account for a larger share of physical material consumption but generally offer lower differentiation.
The midstream segment covers assay development, antibody pairing, membrane coating, reagent formulation, lateral flow assembly, cassette integration, instrument compatibility, packaging, quality management and regulatory registration. Value creation is concentrated in biomarker specificity, analytical performance, production consistency, clinical usability and regulatory access. Downstream users include labor and delivery departments, obstetric emergency assessment units, maternity clinics and clinical laboratories. International specialist brands tend to capture value through established clinical recognition, proprietary assay positioning and mature hospital channels, while Chinese manufacturers compete more strongly through scalable POCT production, broader rapid-test portfolios, OEM capabilities and cost efficiency.
Segment Insights
By Product Type, IGFBP-1 Tests represent the broadest confirmed supplier category, with commercial products available from international diagnostic specialists and numerous Chinese POCT manufacturers. Typical IGFBP-1 lateral flow assays use vaginal specimens and can provide results in approximately five minutes, with Actim PROM using a 25 μg/L cut-off in the extracted specimen. PAMG-1 Tests form a more concentrated product category and include high-sensitivity systems such as AmniSure, which uses a 5 ng/mL sensitivity threshold. Dual Biomarker Tests provide a separate technology route: ROM Plus simultaneously detects IGFBP-1 and AFP, with FDA documentation identifying cut-offs of 5 ng/mL for IGFBP-1 and 150 ng/mL for AFP.
By Assay Method, Lateral Flow Immunochromatographic Tests remain the dominant commercial architecture because they combine rapid turnaround, simple operation and limited equipment requirements. Strip Tests and Cassette Tests are the two established product formats, while fluorescence immunoassays and reader-assisted cassettes represent a smaller but increasingly differentiated direction. By Application, Preterm PROM Testing has high clinical importance because the result can influence pregnancy management before term, while Term PROM Testing provides a separate established demand base. Current leading tests can be used across broad gestational ranges, and some products are specifically positioned for point-of-care use at the bedside or in clinical laboratories.
Downstream Market Opportunities
Labor and delivery point-of-care testing represents the most direct downstream use case because suspected fluid leakage often requires a rapid answer during obstetric assessment. Obstetric emergency departments and maternity assessment units also represent important demand centers, particularly when clinical examination does not provide a definitive diagnosis. Obstetric outpatient point-of-care testing offers additional penetration potential as rapid kits become easier to operate and require less laboratory infrastructure. Clinical laboratories remain relevant for institutions that maintain centralized diagnostic workflows, but the short assay time and relatively simple sample-processing requirements favor continued migration toward near-patient testing. Commercial expansion is therefore increasingly tied to hospital POCT deployment, maternity network coverage and standardized diagnostic pathways rather than population-wide screening.
Regional Insights
North America and Western Europe remain important high-value markets for Prelabor Rupture of Membranes PROM Rapid Tests because established branded systems, structured maternity-care pathways and relatively high diagnostic expenditure support premium products. The United States has established PAMG-1 and dual-biomarker product systems, while Europe has a diversified manufacturing base spanning Finland, France and other regional diagnostic companies. Regulatory access, clinical validation and hospital workflow compatibility are particularly important competitive factors in these markets, creating higher barriers for suppliers competing mainly on price.
China has developed the densest manufacturing cluster within the confirmed global supplier pool, supported by a mature lateral flow and POCT ecosystem and a large number of manufacturers offering IGFBP-1 and related rapid tests. Its competitive advantages are manufacturing scale, OEM capability, rapid product development and lower production costs. Japan, South Korea, India, Southeast Asia and Taiwan currently show a greater dependence on imported products and local distribution within the confirmed supplier universe, creating opportunities around local registration, channel expansion and clinical adoption rather than an equivalent concentration of indigenous manufacturing.
Competitive Landscape Analysis
The competitive landscape combines a small number of internationally established specialist product systems with a broader group of scalable Chinese rapid-diagnostic manufacturers. QIAGEN Sciences is positioned around the PAMG-1-based AmniSure platform, Clinical Innovations within LABORIE operates the IGFBP-1 and AFP-based ROM Plus system, Actim Oy within Medix Biochemica specializes in the IGFBP-1-based Actim PROM platform, and BIOSYNEX maintains IGFBP-1 and dual-biomarker AMNIOQUICK products. TODA PHARMA and Vitrosens add further European and regional competition. The Chinese manufacturing base includes Hangzhou AllTest Biotech, Zhejiang Orient Gene Biotech, Assure Tech Hangzhou, Hangzhou Biotest Biotech, Jiangsu Bioperfectus Technologies, Wuhan EasyDiagnosis Biomedicine, Chengdu VACURE Biotechnology, Jiangsu Macro & Micro-Test Med-Tech, Wuxi BioHermes, Zhuhai Encode Medical Engineering and Hangzhou Testsea Biotechnology. Competition therefore differs by business model: international specialists rely more heavily on clinical recognition, differentiated biomarkers and established hospital channels, while Chinese manufacturers compete through manufacturing scale, portfolio breadth, OEM capabilities and cost efficiency. FDA records continue to identify Clinical Innovations as the applicant for ROM Plus, supporting consolidation of the LABORIE and Clinical Innovations businesses within one competitive group rather than treating them as separate suppliers.
Report Scope
This report delivers a comprehensive overview of the global Prelabor Rupture of Membranes PROM Rapid Tests market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Prelabor Rupture of Membranes PROM Rapid Tests. The Prelabor Rupture of Membranes PROM Rapid Tests market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Prelabor Rupture of Membranes PROM Rapid Tests market comprehensively. Regional market sizes by Type, by Application, by Assay Method, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Prelabor Rupture of Membranes PROM Rapid Tests manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
QIAGEN Sciences LLC
Clinical Innovations, LLC
Actim Oy
BIOSYNEX SA
TODA PHARMA
Vitrosens Biotechnology
Hangzhou AllTest Biotech Co., Ltd.
Zhejiang Orient Gene Biotech Co., Ltd.
Assure Tech Hangzhou Co., Ltd.
Hangzhou Biotest Biotech Co., Ltd.
Jiangsu Bioperfectus Technologies Co., Ltd.
Wuhan EasyDiagnosis Biomedicine Co., Ltd.
Chengdu VACURE Biotechnology Co., Ltd.
Jiangsu Macro & Micro-Test Med-Tech Co., Ltd.
Wuxi BioHermes Bio&Medical Technology Co., Ltd.
Zhuhai Encode Medical Engineering Co., Ltd.
Hangzhou Testsea Biotechnology Co., Ltd.
Segment by Type
PAMG-1 Tests
IGFBP-1 Tests
Dual Biomarker Tests
Other
Segment by Assay Method
Lateral Flow Immunochromatographic Tests
Fluorescence Immunoassay Tests
Other
by Application
Preterm PROM Testing
Term PROM Testing
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Assay Method, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Prelabor Rupture of Membranes PROM Rapid Tests manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Prelabor Rupture of Membranes PROM Rapid Tests sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Prelabor Rupture of Membranes PROM Rapid Tests are in vitro diagnostic products used to support rapid identification of fetal membrane rupture by detecting amniotic-fluid-associated biomarkers in vaginal or cervicovaginal specimens. The market primarily covers qualitative rapid tests targeting placental alpha-microglobulin-1 PAMG-1, insulin-like growth factor binding protein-1 IGFBP-1, and dual-biomarker combinations such as IGFBP-1 and alpha-fetoprotein AFP. Commercial products are predominantly based on lateral flow immunochromatography and are supplied in strip or cassette formats, while fluorescence immunoassay and reader-assisted systems represent an emerging technology route. Typical products combine a sterile collection swab, extraction solution and single-use detection device, with results generally available within approximately 5 to 15 minutes. The products are mainly used for Preterm PROM Testing and Term PROM Testing in labor and delivery departments, obstetric emergency assessment, obstetric outpatient settings and clinical laboratories. Current products range from highly sensitive PAMG-1 assays with thresholds around 5 ng/mL to IGFBP-1 assays with product-specific cut-offs, while dual-biomarker systems provide simultaneous detection of two amniotic-fluid-associated proteins.
Key Findings
IGFBP-1 Tests have the broadest confirmed manufacturing base among current product types
China Europe and the United States form the principal manufacturing centers in the confirmed supplier pool
Market Trends
The Prelabor Rupture of Membranes PROM Rapid Tests market is moving from conventional clinical observation and less specific biochemical methods toward more standardized amniotic-fluid biomarker testing in diagnostically uncertain cases. PAMG-1 and IGFBP-1 remain the principal single-biomarker routes, while dual-biomarker products combining IGFBP-1 and AFP provide an additional differentiation strategy. Product architecture is also evolving from visually interpreted strips toward cassette formats and reader-assisted testing. BIOSYNEX, for example, currently offers IGFBP-1 strip and cassette products as well as an IGFBP-1 and AFP dual-biomarker product that can be configured for automated reading. PAMG-1 products such as AmniSure continue to emphasize high analytical sensitivity and rapid bedside workflow, while the broader market is moving toward easier sampling, standardized interpretation and stronger resistance to potential specimen interference.
Market Dynamics
Drivers
Demand for Prelabor Rupture of Membranes PROM Rapid Tests is supported by the need to rapidly distinguish true membrane rupture from other causes of vaginal fluid leakage, because diagnostic uncertainty can affect observation, antimicrobial management, fetal monitoring and timing of delivery. Biomarker testing has an established role when symptoms suggest rupture but amniotic-fluid pooling is not directly observed during clinical examination. IGFBP-1 and PAMG-1 are incorporated into established diagnostic pathways for suspected preterm membrane rupture, providing a stable clinical foundation for test utilization. Expansion of point-of-care diagnostics, broader availability of rapid immunoassays and improving obstetric diagnostic capacity in emerging healthcare systems are further increasing the addressable testing population.
Restraints
Market penetration is structurally limited because biomarker testing is not required for every pregnancy or every patient presenting with suspected membrane rupture. When amniotic-fluid pooling is clearly observed, additional biochemical testing may not be required, reducing the theoretical testing rate relative to the overall number of PROM cases. Traditional examination, pH-based testing and microscopy also remain available in some institutions. In addition, the market has a wide price spectrum between premium international brands and lower-cost regional products, while the expanding supply base of Chinese lateral flow manufacturers is increasing price competition. As a result, volume growth does not necessarily translate into equivalent growth in average selling prices.
Opportunities
The strongest market opportunity lies in increasing adoption among symptomatic patients whose membrane status remains uncertain after initial clinical assessment rather than in universal screening. Secondary hospitals, regional maternity centers and obstetric outpatient settings in emerging markets remain underpenetrated relative to major tertiary institutions. Additional opportunities are developing around dual-biomarker detection, instrument-assisted interpretation, fluorescence immunoassay and integrated sampling formats that can reduce operator variability. Wider use of rapid tests in decentralized maternity care can also shorten diagnostic turnaround and support more consistent clinical pathways, particularly where access to specialized laboratory testing is limited.
Challenges
The industry faces persistent differences in clinical practice, reimbursement, hospital procurement and regulatory requirements between markets. Assays must maintain reliable performance in specimens potentially affected by blood, semen, urine, vaginal medication or infectious agents, making antibody selection, interference control and lot-to-lot reproducibility important technical barriers. Product positioning also requires clear separation between membrane-rupture diagnosis and adjacent applications such as preterm-birth risk assessment, as some biomarker families are used in both areas. Manufacturers therefore need to balance analytical performance, regulatory compliance and product affordability while facing increasing competition from large-scale lateral flow suppliers.
Industry Chain Analysis
The upstream industry chain includes monoclonal and polyclonal antibodies and other biological reagents targeting PAMG-1, IGFBP-1 and AFP, together with nitrocellulose membranes, sample pads, conjugate pads, colloidal gold, latex or fluorescent signal materials, extraction buffers, sterile swabs, plastic housings and packaging components. Biological reagents and antibody pairing have a disproportionate impact on sensitivity, specificity, interference resistance and batch consistency, while conventional membranes, plastic components and packaging account for a larger share of physical material consumption but generally offer lower differentiation.
The midstream segment covers assay development, antibody pairing, membrane coating, reagent formulation, lateral flow assembly, cassette integration, instrument compatibility, packaging, quality management and regulatory registration. Value creation is concentrated in biomarker specificity, analytical performance, production consistency, clinical usability and regulatory access. Downstream users include labor and delivery departments, obstetric emergency assessment units, maternity clinics and clinical laboratories. International specialist brands tend to capture value through established clinical recognition, proprietary assay positioning and mature hospital channels, while Chinese manufacturers compete more strongly through scalable POCT production, broader rapid-test portfolios, OEM capabilities and cost efficiency.
Segment Insights
By Product Type, IGFBP-1 Tests represent the broadest confirmed supplier category, with commercial products available from international diagnostic specialists and numerous Chinese POCT manufacturers. Typical IGFBP-1 lateral flow assays use vaginal specimens and can provide results in approximately five minutes, with Actim PROM using a 25 μg/L cut-off in the extracted specimen. PAMG-1 Tests form a more concentrated product category and include high-sensitivity systems such as AmniSure, which uses a 5 ng/mL sensitivity threshold. Dual Biomarker Tests provide a separate technology route: ROM Plus simultaneously detects IGFBP-1 and AFP, with FDA documentation identifying cut-offs of 5 ng/mL for IGFBP-1 and 150 ng/mL for AFP.
By Assay Method, Lateral Flow Immunochromatographic Tests remain the dominant commercial architecture because they combine rapid turnaround, simple operation and limited equipment requirements. Strip Tests and Cassette Tests are the two established product formats, while fluorescence immunoassays and reader-assisted cassettes represent a smaller but increasingly differentiated direction. By Application, Preterm PROM Testing has high clinical importance because the result can influence pregnancy management before term, while Term PROM Testing provides a separate established demand base. Current leading tests can be used across broad gestational ranges, and some products are specifically positioned for point-of-care use at the bedside or in clinical laboratories.
Downstream Market Opportunities
Labor and delivery point-of-care testing represents the most direct downstream use case because suspected fluid leakage often requires a rapid answer during obstetric assessment. Obstetric emergency departments and maternity assessment units also represent important demand centers, particularly when clinical examination does not provide a definitive diagnosis. Obstetric outpatient point-of-care testing offers additional penetration potential as rapid kits become easier to operate and require less laboratory infrastructure. Clinical laboratories remain relevant for institutions that maintain centralized diagnostic workflows, but the short assay time and relatively simple sample-processing requirements favor continued migration toward near-patient testing. Commercial expansion is therefore increasingly tied to hospital POCT deployment, maternity network coverage and standardized diagnostic pathways rather than population-wide screening.
Regional Insights
North America and Western Europe remain important high-value markets for Prelabor Rupture of Membranes PROM Rapid Tests because established branded systems, structured maternity-care pathways and relatively high diagnostic expenditure support premium products. The United States has established PAMG-1 and dual-biomarker product systems, while Europe has a diversified manufacturing base spanning Finland, France and other regional diagnostic companies. Regulatory access, clinical validation and hospital workflow compatibility are particularly important competitive factors in these markets, creating higher barriers for suppliers competing mainly on price.
China has developed the densest manufacturing cluster within the confirmed global supplier pool, supported by a mature lateral flow and POCT ecosystem and a large number of manufacturers offering IGFBP-1 and related rapid tests. Its competitive advantages are manufacturing scale, OEM capability, rapid product development and lower production costs. Japan, South Korea, India, Southeast Asia and Taiwan currently show a greater dependence on imported products and local distribution within the confirmed supplier universe, creating opportunities around local registration, channel expansion and clinical adoption rather than an equivalent concentration of indigenous manufacturing.
Competitive Landscape Analysis
The competitive landscape combines a small number of internationally established specialist product systems with a broader group of scalable Chinese rapid-diagnostic manufacturers. QIAGEN Sciences is positioned around the PAMG-1-based AmniSure platform, Clinical Innovations within LABORIE operates the IGFBP-1 and AFP-based ROM Plus system, Actim Oy within Medix Biochemica specializes in the IGFBP-1-based Actim PROM platform, and BIOSYNEX maintains IGFBP-1 and dual-biomarker AMNIOQUICK products. TODA PHARMA and Vitrosens add further European and regional competition. The Chinese manufacturing base includes Hangzhou AllTest Biotech, Zhejiang Orient Gene Biotech, Assure Tech Hangzhou, Hangzhou Biotest Biotech, Jiangsu Bioperfectus Technologies, Wuhan EasyDiagnosis Biomedicine, Chengdu VACURE Biotechnology, Jiangsu Macro & Micro-Test Med-Tech, Wuxi BioHermes, Zhuhai Encode Medical Engineering and Hangzhou Testsea Biotechnology. Competition therefore differs by business model: international specialists rely more heavily on clinical recognition, differentiated biomarkers and established hospital channels, while Chinese manufacturers compete through manufacturing scale, portfolio breadth, OEM capabilities and cost efficiency. FDA records continue to identify Clinical Innovations as the applicant for ROM Plus, supporting consolidation of the LABORIE and Clinical Innovations businesses within one competitive group rather than treating them as separate suppliers.
Report Scope
This report delivers a comprehensive overview of the global Prelabor Rupture of Membranes PROM Rapid Tests market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Prelabor Rupture of Membranes PROM Rapid Tests. The Prelabor Rupture of Membranes PROM Rapid Tests market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Prelabor Rupture of Membranes PROM Rapid Tests market comprehensively. Regional market sizes by Type, by Application, by Assay Method, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Prelabor Rupture of Membranes PROM Rapid Tests manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
QIAGEN Sciences LLC
Clinical Innovations, LLC
Actim Oy
BIOSYNEX SA
TODA PHARMA
Vitrosens Biotechnology
Hangzhou AllTest Biotech Co., Ltd.
Zhejiang Orient Gene Biotech Co., Ltd.
Assure Tech Hangzhou Co., Ltd.
Hangzhou Biotest Biotech Co., Ltd.
Jiangsu Bioperfectus Technologies Co., Ltd.
Wuhan EasyDiagnosis Biomedicine Co., Ltd.
Chengdu VACURE Biotechnology Co., Ltd.
Jiangsu Macro & Micro-Test Med-Tech Co., Ltd.
Wuxi BioHermes Bio&Medical Technology Co., Ltd.
Zhuhai Encode Medical Engineering Co., Ltd.
Hangzhou Testsea Biotechnology Co., Ltd.
Segment by Type
PAMG-1 Tests
IGFBP-1 Tests
Dual Biomarker Tests
Other
Segment by Assay Method
Lateral Flow Immunochromatographic Tests
Fluorescence Immunoassay Tests
Other
by Application
Preterm PROM Testing
Term PROM Testing
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Assay Method, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Prelabor Rupture of Membranes PROM Rapid Tests manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Prelabor Rupture of Membranes PROM Rapid Tests sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Prelabor Rupture of Membranes PROM Rapid Tests Market Overview
1.1 Product Definition
1.2 Prelabor Rupture of Membranes PROM Rapid Tests by Type
1.2.1 Global Prelabor Rupture of Membranes PROM Rapid Tests Market Value by Type: 2025 vs 2032
1.2.2 PAMG-1 Tests
1.2.3 IGFBP-1 Tests
1.2.4 Dual Biomarker Tests
1.2.5 Other
1.3 Prelabor Rupture of Membranes PROM Rapid Tests by Assay Method
1.3.1 Global Prelabor Rupture of Membranes PROM Rapid Tests Market Value by Assay Method: 2025 vs 2032
1.3.2 Lateral Flow Immunochromatographic Tests
1.3.3 Fluorescence Immunoassay Tests
1.3.4 Other
1.4 Prelabor Rupture of Membranes PROM Rapid Tests by Application
1.4.1 Global Prelabor Rupture of Membranes PROM Rapid Tests Market Value by Application: 2025 vs 2032
1.4.2 Preterm PROM Testing
1.4.3 Term PROM Testing
1.4.4 Other
1.5 Global Prelabor Rupture of Membranes PROM Rapid Tests Market Size Estimates and Forecasts
1.5.1 Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue 2021–2032
1.5.2 Global Prelabor Rupture of Membranes PROM Rapid Tests Sales 2021–2032
1.5.3 Global Prelabor Rupture of Membranes PROM Rapid Tests Market Average Price (2021–2032)
1.6 Assumptions and Limitations
2 Prelabor Rupture of Membranes PROM Rapid Tests Market Competition by Manufacturers
2.1 Global Prelabor Rupture of Membranes PROM Rapid Tests Sales Market Share by Manufacturers (2021–2026)
2.2 Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Prelabor Rupture of Membranes PROM Rapid Tests Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Prelabor Rupture of Membranes PROM Rapid Tests, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Prelabor Rupture of Membranes PROM Rapid Tests, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Prelabor Rupture of Membranes PROM Rapid Tests, Product Types and Applications
2.7 Global Key Manufacturers of Prelabor Rupture of Membranes PROM Rapid Tests, Date of Entry into the Industry
2.8 Global Prelabor Rupture of Membranes PROM Rapid Tests Market Competitive Situation and Trends
2.8.1 Global Prelabor Rupture of Membranes PROM Rapid Tests Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Prelabor Rupture of Membranes PROM Rapid Tests Players Market Share by Revenue
2.8.3 Global Prelabor Rupture of Membranes PROM Rapid Tests Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Prelabor Rupture of Membranes PROM Rapid Tests Market Scenario by Region
3.1 Global Prelabor Rupture of Membranes PROM Rapid Tests Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Prelabor Rupture of Membranes PROM Rapid Tests Sales by Region: 2021–2032
3.2.1 Global Prelabor Rupture of Membranes PROM Rapid Tests Sales by Region: 2021–2026
3.2.2 Global Prelabor Rupture of Membranes PROM Rapid Tests Sales by Region: 2027–2032
3.3 Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Region: 2021–2032
3.3.1 Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Region: 2021–2026
3.3.2 Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Region: 2027–2032
3.4 North America Prelabor Rupture of Membranes PROM Rapid Tests Market Facts & Figures by Country
3.4.1 North America Prelabor Rupture of Membranes PROM Rapid Tests Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Prelabor Rupture of Membranes PROM Rapid Tests Sales by Country (2021–2032)
3.4.3 North America Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Prelabor Rupture of Membranes PROM Rapid Tests Market Facts & Figures by Country
3.5.1 Europe Prelabor Rupture of Membranes PROM Rapid Tests Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Prelabor Rupture of Membranes PROM Rapid Tests Sales by Country (2021–2032)
3.5.3 Europe Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Prelabor Rupture of Membranes PROM Rapid Tests Market Facts & Figures by Region
3.6.1 Asia Pacific Prelabor Rupture of Membranes PROM Rapid Tests Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Prelabor Rupture of Membranes PROM Rapid Tests Sales by Region (2021–2032)
3.6.3 Asia Pacific Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Prelabor Rupture of Membranes PROM Rapid Tests Market Facts & Figures by Country
3.7.1 Latin America Prelabor Rupture of Membranes PROM Rapid Tests Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Prelabor Rupture of Membranes PROM Rapid Tests Sales by Country (2021–2032)
3.7.3 Latin America Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Prelabor Rupture of Membranes PROM Rapid Tests Market Facts & Figures by Country
3.8.1 Middle East and Africa Prelabor Rupture of Membranes PROM Rapid Tests Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Prelabor Rupture of Membranes PROM Rapid Tests Sales by Country (2021–2032)
3.8.3 Middle East and Africa Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Prelabor Rupture of Membranes PROM Rapid Tests Sales by Type (2021–2032)
4.1.1 Global Prelabor Rupture of Membranes PROM Rapid Tests Sales by Type (2021–2026)
4.1.2 Global Prelabor Rupture of Membranes PROM Rapid Tests Sales by Type (2027–2032)
4.1.3 Global Prelabor Rupture of Membranes PROM Rapid Tests Sales Market Share by Type (2021–2032)
4.2 Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Type (2021–2032)
4.2.1 Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Type (2021–2026)
4.2.2 Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Type (2027–2032)
4.2.3 Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue Market Share by Type (2021–2032)
4.3 Global Prelabor Rupture of Membranes PROM Rapid Tests Price by Type (2021–2032)
5 Segment by Application
5.1 Global Prelabor Rupture of Membranes PROM Rapid Tests Sales by Application (2021–2032)
5.1.1 Global Prelabor Rupture of Membranes PROM Rapid Tests Sales by Application (2021–2026)
5.1.2 Global Prelabor Rupture of Membranes PROM Rapid Tests Sales by Application (2027–2032)
5.1.3 Global Prelabor Rupture of Membranes PROM Rapid Tests Sales Market Share by Application (2021–2032)
5.2 Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Application (2021–2032)
5.2.1 Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Application (2021–2026)
5.2.2 Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Application (2027–2032)
5.2.3 Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue Market Share by Application (2021–2032)
5.3 Global Prelabor Rupture of Membranes PROM Rapid Tests Price by Application (2021–2032)
6 Key Companies Profiled
6.1 QIAGEN Sciences LLC
6.1.1 QIAGEN Sciences LLC Company Information
6.1.2 QIAGEN Sciences LLC Description and Business Overview
6.1.3 QIAGEN Sciences LLC Prelabor Rupture of Membranes PROM Rapid Tests Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 QIAGEN Sciences LLC Prelabor Rupture of Membranes PROM Rapid Tests Product Portfolio
6.1.5 QIAGEN Sciences LLC Recent Developments/Updates
6.2 Clinical Innovations, LLC
6.2.1 Clinical Innovations, LLC Company Information
6.2.2 Clinical Innovations, LLC Description and Business Overview
6.2.3 Clinical Innovations, LLC Prelabor Rupture of Membranes PROM Rapid Tests Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Clinical Innovations, LLC Prelabor Rupture of Membranes PROM Rapid Tests Product Portfolio
6.2.5 Clinical Innovations, LLC Recent Developments/Updates
6.3 Actim Oy
6.3.1 Actim Oy Company Information
6.3.2 Actim Oy Description and Business Overview
6.3.3 Actim Oy Prelabor Rupture of Membranes PROM Rapid Tests Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Actim Oy Prelabor Rupture of Membranes PROM Rapid Tests Product Portfolio
6.3.5 Actim Oy Recent Developments/Updates
6.4 BIOSYNEX SA
6.4.1 BIOSYNEX SA Company Information
6.4.2 BIOSYNEX SA Description and Business Overview
6.4.3 BIOSYNEX SA Prelabor Rupture of Membranes PROM Rapid Tests Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 BIOSYNEX SA Prelabor Rupture of Membranes PROM Rapid Tests Product Portfolio
6.4.5 BIOSYNEX SA Recent Developments/Updates
6.5 TODA PHARMA
6.5.1 TODA PHARMA Company Information
6.5.2 TODA PHARMA Description and Business Overview
6.5.3 TODA PHARMA Prelabor Rupture of Membranes PROM Rapid Tests Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 TODA PHARMA Prelabor Rupture of Membranes PROM Rapid Tests Product Portfolio
6.5.5 TODA PHARMA Recent Developments/Updates
6.6 Vitrosens Biotechnology
6.6.1 Vitrosens Biotechnology Company Information
6.6.2 Vitrosens Biotechnology Description and Business Overview
6.6.3 Vitrosens Biotechnology Prelabor Rupture of Membranes PROM Rapid Tests Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Vitrosens Biotechnology Prelabor Rupture of Membranes PROM Rapid Tests Product Portfolio
6.6.5 Vitrosens Biotechnology Recent Developments/Updates
6.7 Hangzhou AllTest Biotech Co., Ltd.
6.7.1 Hangzhou AllTest Biotech Co., Ltd. Company Information
6.7.2 Hangzhou AllTest Biotech Co., Ltd. Description and Business Overview
6.7.3 Hangzhou AllTest Biotech Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Hangzhou AllTest Biotech Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Product Portfolio
6.7.5 Hangzhou AllTest Biotech Co., Ltd. Recent Developments/Updates
6.8 Zhejiang Orient Gene Biotech Co., Ltd.
6.8.1 Zhejiang Orient Gene Biotech Co., Ltd. Company Information
6.8.2 Zhejiang Orient Gene Biotech Co., Ltd. Description and Business Overview
6.8.3 Zhejiang Orient Gene Biotech Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Zhejiang Orient Gene Biotech Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Product Portfolio
6.8.5 Zhejiang Orient Gene Biotech Co., Ltd. Recent Developments/Updates
6.9 Assure Tech Hangzhou Co., Ltd.
6.9.1 Assure Tech Hangzhou Co., Ltd. Company Information
6.9.2 Assure Tech Hangzhou Co., Ltd. Description and Business Overview
6.9.3 Assure Tech Hangzhou Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Assure Tech Hangzhou Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Product Portfolio
6.9.5 Assure Tech Hangzhou Co., Ltd. Recent Developments/Updates
6.10 Hangzhou Biotest Biotech Co., Ltd.
6.10.1 Hangzhou Biotest Biotech Co., Ltd. Company Information
6.10.2 Hangzhou Biotest Biotech Co., Ltd. Description and Business Overview
6.10.3 Hangzhou Biotest Biotech Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Hangzhou Biotest Biotech Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Product Portfolio
6.10.5 Hangzhou Biotest Biotech Co., Ltd. Recent Developments/Updates
6.11 Jiangsu Bioperfectus Technologies Co., Ltd.
6.11.1 Jiangsu Bioperfectus Technologies Co., Ltd. Company Information
6.11.2 Jiangsu Bioperfectus Technologies Co., Ltd. Description and Business Overview
6.11.3 Jiangsu Bioperfectus Technologies Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Jiangsu Bioperfectus Technologies Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Product Portfolio
6.11.5 Jiangsu Bioperfectus Technologies Co., Ltd. Recent Developments/Updates
6.12 Wuhan EasyDiagnosis Biomedicine Co., Ltd.
6.12.1 Wuhan EasyDiagnosis Biomedicine Co., Ltd. Company Information
6.12.2 Wuhan EasyDiagnosis Biomedicine Co., Ltd. Description and Business Overview
6.12.3 Wuhan EasyDiagnosis Biomedicine Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Wuhan EasyDiagnosis Biomedicine Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Product Portfolio
6.12.5 Wuhan EasyDiagnosis Biomedicine Co., Ltd. Recent Developments/Updates
6.13 Chengdu VACURE Biotechnology Co., Ltd.
6.13.1 Chengdu VACURE Biotechnology Co., Ltd. Company Information
6.13.2 Chengdu VACURE Biotechnology Co., Ltd. Description and Business Overview
6.13.3 Chengdu VACURE Biotechnology Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Chengdu VACURE Biotechnology Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Product Portfolio
6.13.5 Chengdu VACURE Biotechnology Co., Ltd. Recent Developments/Updates
6.14 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd.
6.14.1 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Company Information
6.14.2 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Description and Business Overview
6.14.3 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Product Portfolio
6.14.5 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Recent Developments/Updates
6.15 Wuxi BioHermes Bio&Medical Technology Co., Ltd.
6.15.1 Wuxi BioHermes Bio&Medical Technology Co., Ltd. Company Information
6.15.2 Wuxi BioHermes Bio&Medical Technology Co., Ltd. Description and Business Overview
6.15.3 Wuxi BioHermes Bio&Medical Technology Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Wuxi BioHermes Bio&Medical Technology Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Product Portfolio
6.15.5 Wuxi BioHermes Bio&Medical Technology Co., Ltd. Recent Developments/Updates
6.16 Zhuhai Encode Medical Engineering Co., Ltd.
6.16.1 Zhuhai Encode Medical Engineering Co., Ltd. Company Information
6.16.2 Zhuhai Encode Medical Engineering Co., Ltd. Description and Business Overview
6.16.3 Zhuhai Encode Medical Engineering Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Zhuhai Encode Medical Engineering Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Product Portfolio
6.16.5 Zhuhai Encode Medical Engineering Co., Ltd. Recent Developments/Updates
6.17 Hangzhou Testsea Biotechnology Co., Ltd.
6.17.1 Hangzhou Testsea Biotechnology Co., Ltd. Company Information
6.17.2 Hangzhou Testsea Biotechnology Co., Ltd. Description and Business Overview
6.17.3 Hangzhou Testsea Biotechnology Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Hangzhou Testsea Biotechnology Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Product Portfolio
6.17.5 Hangzhou Testsea Biotechnology Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Prelabor Rupture of Membranes PROM Rapid Tests Industry Chain Analysis
7.2 Prelabor Rupture of Membranes PROM Rapid Tests Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Prelabor Rupture of Membranes PROM Rapid Tests Production Mode & Process Analysis
7.4 Prelabor Rupture of Membranes PROM Rapid Tests Sales and Marketing
7.4.1 Prelabor Rupture of Membranes PROM Rapid Tests Sales Channels
7.4.2 Prelabor Rupture of Membranes PROM Rapid Tests Distributors
7.5 Prelabor Rupture of Membranes PROM Rapid Tests Customer Analysis
8 Prelabor Rupture of Membranes PROM Rapid Tests Market Dynamics
8.1 Prelabor Rupture of Membranes PROM Rapid Tests Industry Trends
8.2 Prelabor Rupture of Membranes PROM Rapid Tests Market Drivers
8.3 Prelabor Rupture of Membranes PROM Rapid Tests Market Challenges
8.4 Prelabor Rupture of Membranes PROM Rapid Tests Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Prelabor Rupture of Membranes PROM Rapid Tests by Type
1.2.1 Global Prelabor Rupture of Membranes PROM Rapid Tests Market Value by Type: 2025 vs 2032
1.2.2 PAMG-1 Tests
1.2.3 IGFBP-1 Tests
1.2.4 Dual Biomarker Tests
1.2.5 Other
1.3 Prelabor Rupture of Membranes PROM Rapid Tests by Assay Method
1.3.1 Global Prelabor Rupture of Membranes PROM Rapid Tests Market Value by Assay Method: 2025 vs 2032
1.3.2 Lateral Flow Immunochromatographic Tests
1.3.3 Fluorescence Immunoassay Tests
1.3.4 Other
1.4 Prelabor Rupture of Membranes PROM Rapid Tests by Application
1.4.1 Global Prelabor Rupture of Membranes PROM Rapid Tests Market Value by Application: 2025 vs 2032
1.4.2 Preterm PROM Testing
1.4.3 Term PROM Testing
1.4.4 Other
1.5 Global Prelabor Rupture of Membranes PROM Rapid Tests Market Size Estimates and Forecasts
1.5.1 Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue 2021–2032
1.5.2 Global Prelabor Rupture of Membranes PROM Rapid Tests Sales 2021–2032
1.5.3 Global Prelabor Rupture of Membranes PROM Rapid Tests Market Average Price (2021–2032)
1.6 Assumptions and Limitations
2 Prelabor Rupture of Membranes PROM Rapid Tests Market Competition by Manufacturers
2.1 Global Prelabor Rupture of Membranes PROM Rapid Tests Sales Market Share by Manufacturers (2021–2026)
2.2 Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Prelabor Rupture of Membranes PROM Rapid Tests Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Prelabor Rupture of Membranes PROM Rapid Tests, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Prelabor Rupture of Membranes PROM Rapid Tests, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Prelabor Rupture of Membranes PROM Rapid Tests, Product Types and Applications
2.7 Global Key Manufacturers of Prelabor Rupture of Membranes PROM Rapid Tests, Date of Entry into the Industry
2.8 Global Prelabor Rupture of Membranes PROM Rapid Tests Market Competitive Situation and Trends
2.8.1 Global Prelabor Rupture of Membranes PROM Rapid Tests Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Prelabor Rupture of Membranes PROM Rapid Tests Players Market Share by Revenue
2.8.3 Global Prelabor Rupture of Membranes PROM Rapid Tests Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Prelabor Rupture of Membranes PROM Rapid Tests Market Scenario by Region
3.1 Global Prelabor Rupture of Membranes PROM Rapid Tests Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Prelabor Rupture of Membranes PROM Rapid Tests Sales by Region: 2021–2032
3.2.1 Global Prelabor Rupture of Membranes PROM Rapid Tests Sales by Region: 2021–2026
3.2.2 Global Prelabor Rupture of Membranes PROM Rapid Tests Sales by Region: 2027–2032
3.3 Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Region: 2021–2032
3.3.1 Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Region: 2021–2026
3.3.2 Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Region: 2027–2032
3.4 North America Prelabor Rupture of Membranes PROM Rapid Tests Market Facts & Figures by Country
3.4.1 North America Prelabor Rupture of Membranes PROM Rapid Tests Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Prelabor Rupture of Membranes PROM Rapid Tests Sales by Country (2021–2032)
3.4.3 North America Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Prelabor Rupture of Membranes PROM Rapid Tests Market Facts & Figures by Country
3.5.1 Europe Prelabor Rupture of Membranes PROM Rapid Tests Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Prelabor Rupture of Membranes PROM Rapid Tests Sales by Country (2021–2032)
3.5.3 Europe Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Prelabor Rupture of Membranes PROM Rapid Tests Market Facts & Figures by Region
3.6.1 Asia Pacific Prelabor Rupture of Membranes PROM Rapid Tests Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Prelabor Rupture of Membranes PROM Rapid Tests Sales by Region (2021–2032)
3.6.3 Asia Pacific Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Prelabor Rupture of Membranes PROM Rapid Tests Market Facts & Figures by Country
3.7.1 Latin America Prelabor Rupture of Membranes PROM Rapid Tests Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Prelabor Rupture of Membranes PROM Rapid Tests Sales by Country (2021–2032)
3.7.3 Latin America Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Prelabor Rupture of Membranes PROM Rapid Tests Market Facts & Figures by Country
3.8.1 Middle East and Africa Prelabor Rupture of Membranes PROM Rapid Tests Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Prelabor Rupture of Membranes PROM Rapid Tests Sales by Country (2021–2032)
3.8.3 Middle East and Africa Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Prelabor Rupture of Membranes PROM Rapid Tests Sales by Type (2021–2032)
4.1.1 Global Prelabor Rupture of Membranes PROM Rapid Tests Sales by Type (2021–2026)
4.1.2 Global Prelabor Rupture of Membranes PROM Rapid Tests Sales by Type (2027–2032)
4.1.3 Global Prelabor Rupture of Membranes PROM Rapid Tests Sales Market Share by Type (2021–2032)
4.2 Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Type (2021–2032)
4.2.1 Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Type (2021–2026)
4.2.2 Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Type (2027–2032)
4.2.3 Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue Market Share by Type (2021–2032)
4.3 Global Prelabor Rupture of Membranes PROM Rapid Tests Price by Type (2021–2032)
5 Segment by Application
5.1 Global Prelabor Rupture of Membranes PROM Rapid Tests Sales by Application (2021–2032)
5.1.1 Global Prelabor Rupture of Membranes PROM Rapid Tests Sales by Application (2021–2026)
5.1.2 Global Prelabor Rupture of Membranes PROM Rapid Tests Sales by Application (2027–2032)
5.1.3 Global Prelabor Rupture of Membranes PROM Rapid Tests Sales Market Share by Application (2021–2032)
5.2 Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Application (2021–2032)
5.2.1 Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Application (2021–2026)
5.2.2 Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Application (2027–2032)
5.2.3 Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue Market Share by Application (2021–2032)
5.3 Global Prelabor Rupture of Membranes PROM Rapid Tests Price by Application (2021–2032)
6 Key Companies Profiled
6.1 QIAGEN Sciences LLC
6.1.1 QIAGEN Sciences LLC Company Information
6.1.2 QIAGEN Sciences LLC Description and Business Overview
6.1.3 QIAGEN Sciences LLC Prelabor Rupture of Membranes PROM Rapid Tests Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 QIAGEN Sciences LLC Prelabor Rupture of Membranes PROM Rapid Tests Product Portfolio
6.1.5 QIAGEN Sciences LLC Recent Developments/Updates
6.2 Clinical Innovations, LLC
6.2.1 Clinical Innovations, LLC Company Information
6.2.2 Clinical Innovations, LLC Description and Business Overview
6.2.3 Clinical Innovations, LLC Prelabor Rupture of Membranes PROM Rapid Tests Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Clinical Innovations, LLC Prelabor Rupture of Membranes PROM Rapid Tests Product Portfolio
6.2.5 Clinical Innovations, LLC Recent Developments/Updates
6.3 Actim Oy
6.3.1 Actim Oy Company Information
6.3.2 Actim Oy Description and Business Overview
6.3.3 Actim Oy Prelabor Rupture of Membranes PROM Rapid Tests Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Actim Oy Prelabor Rupture of Membranes PROM Rapid Tests Product Portfolio
6.3.5 Actim Oy Recent Developments/Updates
6.4 BIOSYNEX SA
6.4.1 BIOSYNEX SA Company Information
6.4.2 BIOSYNEX SA Description and Business Overview
6.4.3 BIOSYNEX SA Prelabor Rupture of Membranes PROM Rapid Tests Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 BIOSYNEX SA Prelabor Rupture of Membranes PROM Rapid Tests Product Portfolio
6.4.5 BIOSYNEX SA Recent Developments/Updates
6.5 TODA PHARMA
6.5.1 TODA PHARMA Company Information
6.5.2 TODA PHARMA Description and Business Overview
6.5.3 TODA PHARMA Prelabor Rupture of Membranes PROM Rapid Tests Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 TODA PHARMA Prelabor Rupture of Membranes PROM Rapid Tests Product Portfolio
6.5.5 TODA PHARMA Recent Developments/Updates
6.6 Vitrosens Biotechnology
6.6.1 Vitrosens Biotechnology Company Information
6.6.2 Vitrosens Biotechnology Description and Business Overview
6.6.3 Vitrosens Biotechnology Prelabor Rupture of Membranes PROM Rapid Tests Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Vitrosens Biotechnology Prelabor Rupture of Membranes PROM Rapid Tests Product Portfolio
6.6.5 Vitrosens Biotechnology Recent Developments/Updates
6.7 Hangzhou AllTest Biotech Co., Ltd.
6.7.1 Hangzhou AllTest Biotech Co., Ltd. Company Information
6.7.2 Hangzhou AllTest Biotech Co., Ltd. Description and Business Overview
6.7.3 Hangzhou AllTest Biotech Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Hangzhou AllTest Biotech Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Product Portfolio
6.7.5 Hangzhou AllTest Biotech Co., Ltd. Recent Developments/Updates
6.8 Zhejiang Orient Gene Biotech Co., Ltd.
6.8.1 Zhejiang Orient Gene Biotech Co., Ltd. Company Information
6.8.2 Zhejiang Orient Gene Biotech Co., Ltd. Description and Business Overview
6.8.3 Zhejiang Orient Gene Biotech Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Zhejiang Orient Gene Biotech Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Product Portfolio
6.8.5 Zhejiang Orient Gene Biotech Co., Ltd. Recent Developments/Updates
6.9 Assure Tech Hangzhou Co., Ltd.
6.9.1 Assure Tech Hangzhou Co., Ltd. Company Information
6.9.2 Assure Tech Hangzhou Co., Ltd. Description and Business Overview
6.9.3 Assure Tech Hangzhou Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Assure Tech Hangzhou Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Product Portfolio
6.9.5 Assure Tech Hangzhou Co., Ltd. Recent Developments/Updates
6.10 Hangzhou Biotest Biotech Co., Ltd.
6.10.1 Hangzhou Biotest Biotech Co., Ltd. Company Information
6.10.2 Hangzhou Biotest Biotech Co., Ltd. Description and Business Overview
6.10.3 Hangzhou Biotest Biotech Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Hangzhou Biotest Biotech Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Product Portfolio
6.10.5 Hangzhou Biotest Biotech Co., Ltd. Recent Developments/Updates
6.11 Jiangsu Bioperfectus Technologies Co., Ltd.
6.11.1 Jiangsu Bioperfectus Technologies Co., Ltd. Company Information
6.11.2 Jiangsu Bioperfectus Technologies Co., Ltd. Description and Business Overview
6.11.3 Jiangsu Bioperfectus Technologies Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Jiangsu Bioperfectus Technologies Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Product Portfolio
6.11.5 Jiangsu Bioperfectus Technologies Co., Ltd. Recent Developments/Updates
6.12 Wuhan EasyDiagnosis Biomedicine Co., Ltd.
6.12.1 Wuhan EasyDiagnosis Biomedicine Co., Ltd. Company Information
6.12.2 Wuhan EasyDiagnosis Biomedicine Co., Ltd. Description and Business Overview
6.12.3 Wuhan EasyDiagnosis Biomedicine Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Wuhan EasyDiagnosis Biomedicine Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Product Portfolio
6.12.5 Wuhan EasyDiagnosis Biomedicine Co., Ltd. Recent Developments/Updates
6.13 Chengdu VACURE Biotechnology Co., Ltd.
6.13.1 Chengdu VACURE Biotechnology Co., Ltd. Company Information
6.13.2 Chengdu VACURE Biotechnology Co., Ltd. Description and Business Overview
6.13.3 Chengdu VACURE Biotechnology Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Chengdu VACURE Biotechnology Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Product Portfolio
6.13.5 Chengdu VACURE Biotechnology Co., Ltd. Recent Developments/Updates
6.14 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd.
6.14.1 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Company Information
6.14.2 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Description and Business Overview
6.14.3 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Product Portfolio
6.14.5 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Recent Developments/Updates
6.15 Wuxi BioHermes Bio&Medical Technology Co., Ltd.
6.15.1 Wuxi BioHermes Bio&Medical Technology Co., Ltd. Company Information
6.15.2 Wuxi BioHermes Bio&Medical Technology Co., Ltd. Description and Business Overview
6.15.3 Wuxi BioHermes Bio&Medical Technology Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Wuxi BioHermes Bio&Medical Technology Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Product Portfolio
6.15.5 Wuxi BioHermes Bio&Medical Technology Co., Ltd. Recent Developments/Updates
6.16 Zhuhai Encode Medical Engineering Co., Ltd.
6.16.1 Zhuhai Encode Medical Engineering Co., Ltd. Company Information
6.16.2 Zhuhai Encode Medical Engineering Co., Ltd. Description and Business Overview
6.16.3 Zhuhai Encode Medical Engineering Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Zhuhai Encode Medical Engineering Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Product Portfolio
6.16.5 Zhuhai Encode Medical Engineering Co., Ltd. Recent Developments/Updates
6.17 Hangzhou Testsea Biotechnology Co., Ltd.
6.17.1 Hangzhou Testsea Biotechnology Co., Ltd. Company Information
6.17.2 Hangzhou Testsea Biotechnology Co., Ltd. Description and Business Overview
6.17.3 Hangzhou Testsea Biotechnology Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Hangzhou Testsea Biotechnology Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Product Portfolio
6.17.5 Hangzhou Testsea Biotechnology Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Prelabor Rupture of Membranes PROM Rapid Tests Industry Chain Analysis
7.2 Prelabor Rupture of Membranes PROM Rapid Tests Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Prelabor Rupture of Membranes PROM Rapid Tests Production Mode & Process Analysis
7.4 Prelabor Rupture of Membranes PROM Rapid Tests Sales and Marketing
7.4.1 Prelabor Rupture of Membranes PROM Rapid Tests Sales Channels
7.4.2 Prelabor Rupture of Membranes PROM Rapid Tests Distributors
7.5 Prelabor Rupture of Membranes PROM Rapid Tests Customer Analysis
8 Prelabor Rupture of Membranes PROM Rapid Tests Market Dynamics
8.1 Prelabor Rupture of Membranes PROM Rapid Tests Industry Trends
8.2 Prelabor Rupture of Membranes PROM Rapid Tests Market Drivers
8.3 Prelabor Rupture of Membranes PROM Rapid Tests Market Challenges
8.4 Prelabor Rupture of Membranes PROM Rapid Tests Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Prelabor Rupture of Membranes PROM Rapid Tests Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Prelabor Rupture of Membranes PROM Rapid Tests Market Value by Assay Method (US$ Million), 2025 vs 2032
Table 3. Global Prelabor Rupture of Membranes PROM Rapid Tests Market Value by Application (US$ Million), 2025 vs 2032
Table 4. Global Prelabor Rupture of Membranes PROM Rapid Tests Market Competitive Situation by Manufacturers in 2025
Table 5. Global Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units) of Key Manufacturers (2021–2026)
Table 6. Global Prelabor Rupture of Membranes PROM Rapid Tests Sales Market Share by Manufacturers (2021–2026)
Table 7. Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue (US$ Million) by Manufacturers (2021–2026)
Table 8. Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue Share by Manufacturers (2021–2026)
Table 9. Global Market Prelabor Rupture of Membranes PROM Rapid Tests Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 10. Global Key Players of Prelabor Rupture of Membranes PROM Rapid Tests, Industry Ranking, 2023 vs 2024 vs 2025
Table 11. Global Key Manufacturers of Prelabor Rupture of Membranes PROM Rapid Tests, Manufacturing Sites and Headquarters
Table 12. Global Key Manufacturers of Prelabor Rupture of Membranes PROM Rapid Tests, Product Types and Applications
Table 13. Global Key Manufacturers of Prelabor Rupture of Membranes PROM Rapid Tests, Date of Entry into the Industry
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Prelabor Rupture of Membranes PROM Rapid Tests Companies by Tier (Tier 1, Tier 2, Tier 3), based on Prelabor Rupture of Membranes PROM Rapid Tests Revenue, 2025
Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 17. Global Prelabor Rupture of Membranes PROM Rapid Tests Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 18. Global Prelabor Rupture of Membranes PROM Rapid Tests Sales by Region (Units), 2021–2026
Table 19. Global Prelabor Rupture of Membranes PROM Rapid Tests Sales Market Share by Region (2021–2026)
Table 20. Global Prelabor Rupture of Membranes PROM Rapid Tests Sales by Region (Units), 2027–2032
Table 21. Global Prelabor Rupture of Membranes PROM Rapid Tests Sales Market Share by Region (2027–2032)
Table 22. Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Region (US$ Million), 2021–2026
Table 23. Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue Market Share by Region (2021–2026)
Table 24. Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Region (US$ Million), 2027–2032
Table 25. Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue Market Share by Region (2027–2032)
Table 26. North America Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 27. North America Prelabor Rupture of Membranes PROM Rapid Tests Sales by Country (Units), 2021–2026
Table 28. North America Prelabor Rupture of Membranes PROM Rapid Tests Sales by Country (Units), 2027–2032
Table 29. North America Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Country (US$ Million), 2021–2026
Table 30. North America Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Country (US$ Million), 2027–2032
Table 31. Europe Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 32. Europe Prelabor Rupture of Membranes PROM Rapid Tests Sales by Country (Units), 2021–2026
Table 33. Europe Prelabor Rupture of Membranes PROM Rapid Tests Sales by Country (Units), 2027–2032
Table 34. Europe Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Country (US$ Million), 2021–2026
Table 35. Europe Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Country (US$ Million), 2027–2032
Table 36. Asia Pacific Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 37. Asia Pacific Prelabor Rupture of Membranes PROM Rapid Tests Sales by Region (Units), 2021–2026
Table 38. Asia Pacific Prelabor Rupture of Membranes PROM Rapid Tests Sales by Region (Units), 2027–2032
Table 39. Asia Pacific Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Region (US$ Million), 2021–2026
Table 40. Asia Pacific Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Region (US$ Million), 2027–2032
Table 41. Latin America Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 42. Latin America Prelabor Rupture of Membranes PROM Rapid Tests Sales by Country (Units), 2021–2026
Table 43. Latin America Prelabor Rupture of Membranes PROM Rapid Tests Sales by Country (Units), 2027–2032
Table 44. Latin America Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Country (US$ Million), 2021–2026
Table 45. Latin America Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Country (US$ Million), 2027–2032
Table 46. Middle East and Africa Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 47. Middle East and Africa Prelabor Rupture of Membranes PROM Rapid Tests Sales by Country (Units), 2021–2026
Table 48. Middle East and Africa Prelabor Rupture of Membranes PROM Rapid Tests Sales by Country (Units), 2027–2032
Table 49. Middle East and Africa Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Country (US$ Million), 2021–2026
Table 50. Middle East and Africa Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Country (US$ Million), 2027–2032
Table 51. Global Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units) by Type (2021–2026)
Table 52. Global Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units) by Type (2027–2032)
Table 53. Global Prelabor Rupture of Membranes PROM Rapid Tests Sales Market Share by Type (2021–2026)
Table 54. Global Prelabor Rupture of Membranes PROM Rapid Tests Sales Market Share by Type (2027–2032)
Table 55. Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue (US$ Million) by Type (2021–2026)
Table 56. Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue (US$ Million) by Type (2027–2032)
Table 57. Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue Market Share by Type (2021–2026)
Table 58. Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue Market Share by Type (2027–2032)
Table 59. Global Prelabor Rupture of Membranes PROM Rapid Tests Price (US$/Unit) by Type (2021–2026)
Table 60. Global Prelabor Rupture of Membranes PROM Rapid Tests Price (US$/Unit) by Type (2027–2032)
Table 61. Global Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units) by Application (2021–2026)
Table 62. Global Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units) by Application (2027–2032)
Table 63. Global Prelabor Rupture of Membranes PROM Rapid Tests Sales Market Share by Application (2021–2026)
Table 64. Global Prelabor Rupture of Membranes PROM Rapid Tests Sales Market Share by Application (2027–2032)
Table 65. Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue (US$ Million) by Application (2021–2026)
Table 66. Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue (US$ Million) by Application (2027–2032)
Table 67. Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue Market Share by Application (2021–2026)
Table 68. Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue Market Share by Application (2027–2032)
Table 69. Global Prelabor Rupture of Membranes PROM Rapid Tests Price (US$/Unit) by Application (2021–2026)
Table 70. Global Prelabor Rupture of Membranes PROM Rapid Tests Price (US$/Unit) by Application (2027–2032)
Table 71. QIAGEN Sciences LLC Company Information
Table 72. QIAGEN Sciences LLC Description and Business Overview
Table 73. QIAGEN Sciences LLC Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 74. QIAGEN Sciences LLC Prelabor Rupture of Membranes PROM Rapid Tests Product
Table 75. QIAGEN Sciences LLC Recent Developments/Updates
Table 76. Clinical Innovations, LLC Company Information
Table 77. Clinical Innovations, LLC Description and Business Overview
Table 78. Clinical Innovations, LLC Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 79. Clinical Innovations, LLC Prelabor Rupture of Membranes PROM Rapid Tests Product
Table 80. Clinical Innovations, LLC Recent Developments/Updates
Table 81. Actim Oy Company Information
Table 82. Actim Oy Description and Business Overview
Table 83. Actim Oy Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 84. Actim Oy Prelabor Rupture of Membranes PROM Rapid Tests Product
Table 85. Actim Oy Recent Developments/Updates
Table 86. BIOSYNEX SA Company Information
Table 87. BIOSYNEX SA Description and Business Overview
Table 88. BIOSYNEX SA Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 89. BIOSYNEX SA Prelabor Rupture of Membranes PROM Rapid Tests Product
Table 90. BIOSYNEX SA Recent Developments/Updates
Table 91. TODA PHARMA Company Information
Table 92. TODA PHARMA Description and Business Overview
Table 93. TODA PHARMA Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 94. TODA PHARMA Prelabor Rupture of Membranes PROM Rapid Tests Product
Table 95. TODA PHARMA Recent Developments/Updates
Table 96. Vitrosens Biotechnology Company Information
Table 97. Vitrosens Biotechnology Description and Business Overview
Table 98. Vitrosens Biotechnology Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 99. Vitrosens Biotechnology Prelabor Rupture of Membranes PROM Rapid Tests Product
Table 100. Vitrosens Biotechnology Recent Developments/Updates
Table 101. Hangzhou AllTest Biotech Co., Ltd. Company Information
Table 102. Hangzhou AllTest Biotech Co., Ltd. Description and Business Overview
Table 103. Hangzhou AllTest Biotech Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 104. Hangzhou AllTest Biotech Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Product
Table 105. Hangzhou AllTest Biotech Co., Ltd. Recent Developments/Updates
Table 106. Zhejiang Orient Gene Biotech Co., Ltd. Company Information
Table 107. Zhejiang Orient Gene Biotech Co., Ltd. Description and Business Overview
Table 108. Zhejiang Orient Gene Biotech Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 109. Zhejiang Orient Gene Biotech Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Product
Table 110. Zhejiang Orient Gene Biotech Co., Ltd. Recent Developments/Updates
Table 111. Assure Tech Hangzhou Co., Ltd. Company Information
Table 112. Assure Tech Hangzhou Co., Ltd. Description and Business Overview
Table 113. Assure Tech Hangzhou Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 114. Assure Tech Hangzhou Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Product
Table 115. Assure Tech Hangzhou Co., Ltd. Recent Developments/Updates
Table 116. Hangzhou Biotest Biotech Co., Ltd. Company Information
Table 117. Hangzhou Biotest Biotech Co., Ltd. Description and Business Overview
Table 118. Hangzhou Biotest Biotech Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 119. Hangzhou Biotest Biotech Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Product
Table 120. Hangzhou Biotest Biotech Co., Ltd. Recent Developments/Updates
Table 121. Jiangsu Bioperfectus Technologies Co., Ltd. Company Information
Table 122. Jiangsu Bioperfectus Technologies Co., Ltd. Description and Business Overview
Table 123. Jiangsu Bioperfectus Technologies Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 124. Jiangsu Bioperfectus Technologies Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Product
Table 125. Jiangsu Bioperfectus Technologies Co., Ltd. Recent Developments/Updates
Table 126. Wuhan EasyDiagnosis Biomedicine Co., Ltd. Company Information
Table 127. Wuhan EasyDiagnosis Biomedicine Co., Ltd. Description and Business Overview
Table 128. Wuhan EasyDiagnosis Biomedicine Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 129. Wuhan EasyDiagnosis Biomedicine Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Product
Table 130. Wuhan EasyDiagnosis Biomedicine Co., Ltd. Recent Developments/Updates
Table 131. Chengdu VACURE Biotechnology Co., Ltd. Company Information
Table 132. Chengdu VACURE Biotechnology Co., Ltd. Description and Business Overview
Table 133. Chengdu VACURE Biotechnology Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 134. Chengdu VACURE Biotechnology Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Product
Table 135. Chengdu VACURE Biotechnology Co., Ltd. Recent Developments/Updates
Table 136. Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Company Information
Table 137. Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Description and Business Overview
Table 138. Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 139. Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Product
Table 140. Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Recent Developments/Updates
Table 141. Wuxi BioHermes Bio&Medical Technology Co., Ltd. Company Information
Table 142. Wuxi BioHermes Bio&Medical Technology Co., Ltd. Description and Business Overview
Table 143. Wuxi BioHermes Bio&Medical Technology Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 144. Wuxi BioHermes Bio&Medical Technology Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Product
Table 145. Wuxi BioHermes Bio&Medical Technology Co., Ltd. Recent Developments/Updates
Table 146. Zhuhai Encode Medical Engineering Co., Ltd. Company Information
Table 147. Zhuhai Encode Medical Engineering Co., Ltd. Description and Business Overview
Table 148. Zhuhai Encode Medical Engineering Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 149. Zhuhai Encode Medical Engineering Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Product
Table 150. Zhuhai Encode Medical Engineering Co., Ltd. Recent Developments/Updates
Table 151. Hangzhou Testsea Biotechnology Co., Ltd. Company Information
Table 152. Hangzhou Testsea Biotechnology Co., Ltd. Description and Business Overview
Table 153. Hangzhou Testsea Biotechnology Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 154. Hangzhou Testsea Biotechnology Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Product
Table 155. Hangzhou Testsea Biotechnology Co., Ltd. Recent Developments/Updates
Table 156. Key Raw Materials Lists
Table 157. Raw Materials Key Suppliers Lists
Table 158. Prelabor Rupture of Membranes PROM Rapid Tests Distributors List
Table 159. Prelabor Rupture of Membranes PROM Rapid Tests Customers List
Table 160. Prelabor Rupture of Membranes PROM Rapid Tests Market Trends
Table 161. Prelabor Rupture of Membranes PROM Rapid Tests Market Drivers
Table 162. Prelabor Rupture of Membranes PROM Rapid Tests Market Challenges
Table 163. Prelabor Rupture of Membranes PROM Rapid Tests Market Restraints
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
Table 167. Authors List of This Report
List of Figures
Figure 1. Product Picture of Prelabor Rupture of Membranes PROM Rapid Tests
Figure 2. Global Prelabor Rupture of Membranes PROM Rapid Tests Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Prelabor Rupture of Membranes PROM Rapid Tests Market Share by Type: 2025 & 2032
Figure 4. PAMG-1 Tests Product Picture
Figure 5. IGFBP-1 Tests Product Picture
Figure 6. Dual Biomarker Tests Product Picture
Figure 7. Other Product Picture
Figure 8. Global Prelabor Rupture of Membranes PROM Rapid Tests Market Value by Assay Method (US$ Million), 2021–2032
Figure 9. Global Prelabor Rupture of Membranes PROM Rapid Tests Market Share by Assay Method: 2025 vs 2032
Figure 10. Lateral Flow Immunochromatographic Tests Product Picture
Figure 11. Fluorescence Immunoassay Tests Product Picture
Figure 12. Other Product Picture
Figure 13. Global Prelabor Rupture of Membranes PROM Rapid Tests Market Value by Application (US$ Million), 2021–2032
Figure 14. Global Prelabor Rupture of Membranes PROM Rapid Tests Market Share by Application: 2025 & 2032
Figure 15. Preterm PROM Testing
Figure 16. Term PROM Testing
Figure 17. Other
Figure 18. Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 19. Global Prelabor Rupture of Membranes PROM Rapid Tests Market Size (US$ Million), 2021–2032
Figure 20. Global Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units), 2021–2032
Figure 21. Global Prelabor Rupture of Membranes PROM Rapid Tests Average Price (US$/Unit), 2021–2032
Figure 22. Prelabor Rupture of Membranes PROM Rapid Tests Report Years Considered
Figure 23. Prelabor Rupture of Membranes PROM Rapid Tests Sales Share by Manufacturers in 2025
Figure 24. Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue Share by Manufacturers in 2025
Figure 25. Top 5 and Top 10 Global Prelabor Rupture of Membranes PROM Rapid Tests Players: Market Share by Revenue in Prelabor Rupture of Membranes PROM Rapid Tests in 2025
Figure 26. Prelabor Rupture of Membranes PROM Rapid Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 27. Global Prelabor Rupture of Membranes PROM Rapid Tests Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 28. North America Prelabor Rupture of Membranes PROM Rapid Tests Sales Market Share by Country (2021–2032)
Figure 29. North America Prelabor Rupture of Membranes PROM Rapid Tests Revenue Market Share by Country (2021–2032)
Figure 30. United States Prelabor Rupture of Membranes PROM Rapid Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Canada Prelabor Rupture of Membranes PROM Rapid Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Europe Prelabor Rupture of Membranes PROM Rapid Tests Sales Market Share by Country (2021–2032)
Figure 33. Europe Prelabor Rupture of Membranes PROM Rapid Tests Revenue Market Share by Country (2021–2032)
Figure 34. Germany Prelabor Rupture of Membranes PROM Rapid Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. France Prelabor Rupture of Membranes PROM Rapid Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. U.K. Prelabor Rupture of Membranes PROM Rapid Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Italy Prelabor Rupture of Membranes PROM Rapid Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Russia Prelabor Rupture of Membranes PROM Rapid Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Asia Pacific Prelabor Rupture of Membranes PROM Rapid Tests Sales Market Share by Region (2021–2032)
Figure 40. Asia Pacific Prelabor Rupture of Membranes PROM Rapid Tests Revenue Market Share by Region (2021–2032)
Figure 41. China Prelabor Rupture of Membranes PROM Rapid Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Japan Prelabor Rupture of Membranes PROM Rapid Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. South Korea Prelabor Rupture of Membranes PROM Rapid Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. India Prelabor Rupture of Membranes PROM Rapid Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Australia Prelabor Rupture of Membranes PROM Rapid Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. China Taiwan Prelabor Rupture of Membranes PROM Rapid Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Southeast Asia Prelabor Rupture of Membranes PROM Rapid Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Latin America Prelabor Rupture of Membranes PROM Rapid Tests Sales Market Share by Country (2021–2032)
Figure 49. Latin America Prelabor Rupture of Membranes PROM Rapid Tests Revenue Market Share by Country (2021–2032)
Figure 50. Mexico Prelabor Rupture of Membranes PROM Rapid Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Brazil Prelabor Rupture of Membranes PROM Rapid Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Argentina Prelabor Rupture of Membranes PROM Rapid Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Colombia Prelabor Rupture of Membranes PROM Rapid Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Middle East and Africa Prelabor Rupture of Membranes PROM Rapid Tests Sales Market Share by Country (2021–2032)
Figure 55. Middle East and Africa Prelabor Rupture of Membranes PROM Rapid Tests Revenue Market Share by Country (2021–2032)
Figure 56. Turkey Prelabor Rupture of Membranes PROM Rapid Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. Saudi Arabia Prelabor Rupture of Membranes PROM Rapid Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. UAE Prelabor Rupture of Membranes PROM Rapid Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 59. Global Sales Market Share of Prelabor Rupture of Membranes PROM Rapid Tests by Type (2021–2032)
Figure 60. Global Revenue Market Share of Prelabor Rupture of Membranes PROM Rapid Tests by Type (2021–2032)
Figure 61. Global Prelabor Rupture of Membranes PROM Rapid Tests Price (US$/Unit) by Type (2021–2032)
Figure 62. Global Sales Market Share of Prelabor Rupture of Membranes PROM Rapid Tests by Application (2021–2032)
Figure 63. Global Revenue Market Share of Prelabor Rupture of Membranes PROM Rapid Tests by Application (2021–2032)
Figure 64. Global Prelabor Rupture of Membranes PROM Rapid Tests Price (US$/Unit) by Application (2021–2032)
Figure 65. Prelabor Rupture of Membranes PROM Rapid Tests Value Chain
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Table 1. Global Prelabor Rupture of Membranes PROM Rapid Tests Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Prelabor Rupture of Membranes PROM Rapid Tests Market Value by Assay Method (US$ Million), 2025 vs 2032
Table 3. Global Prelabor Rupture of Membranes PROM Rapid Tests Market Value by Application (US$ Million), 2025 vs 2032
Table 4. Global Prelabor Rupture of Membranes PROM Rapid Tests Market Competitive Situation by Manufacturers in 2025
Table 5. Global Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units) of Key Manufacturers (2021–2026)
Table 6. Global Prelabor Rupture of Membranes PROM Rapid Tests Sales Market Share by Manufacturers (2021–2026)
Table 7. Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue (US$ Million) by Manufacturers (2021–2026)
Table 8. Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue Share by Manufacturers (2021–2026)
Table 9. Global Market Prelabor Rupture of Membranes PROM Rapid Tests Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 10. Global Key Players of Prelabor Rupture of Membranes PROM Rapid Tests, Industry Ranking, 2023 vs 2024 vs 2025
Table 11. Global Key Manufacturers of Prelabor Rupture of Membranes PROM Rapid Tests, Manufacturing Sites and Headquarters
Table 12. Global Key Manufacturers of Prelabor Rupture of Membranes PROM Rapid Tests, Product Types and Applications
Table 13. Global Key Manufacturers of Prelabor Rupture of Membranes PROM Rapid Tests, Date of Entry into the Industry
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Prelabor Rupture of Membranes PROM Rapid Tests Companies by Tier (Tier 1, Tier 2, Tier 3), based on Prelabor Rupture of Membranes PROM Rapid Tests Revenue, 2025
Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 17. Global Prelabor Rupture of Membranes PROM Rapid Tests Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 18. Global Prelabor Rupture of Membranes PROM Rapid Tests Sales by Region (Units), 2021–2026
Table 19. Global Prelabor Rupture of Membranes PROM Rapid Tests Sales Market Share by Region (2021–2026)
Table 20. Global Prelabor Rupture of Membranes PROM Rapid Tests Sales by Region (Units), 2027–2032
Table 21. Global Prelabor Rupture of Membranes PROM Rapid Tests Sales Market Share by Region (2027–2032)
Table 22. Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Region (US$ Million), 2021–2026
Table 23. Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue Market Share by Region (2021–2026)
Table 24. Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Region (US$ Million), 2027–2032
Table 25. Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue Market Share by Region (2027–2032)
Table 26. North America Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 27. North America Prelabor Rupture of Membranes PROM Rapid Tests Sales by Country (Units), 2021–2026
Table 28. North America Prelabor Rupture of Membranes PROM Rapid Tests Sales by Country (Units), 2027–2032
Table 29. North America Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Country (US$ Million), 2021–2026
Table 30. North America Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Country (US$ Million), 2027–2032
Table 31. Europe Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 32. Europe Prelabor Rupture of Membranes PROM Rapid Tests Sales by Country (Units), 2021–2026
Table 33. Europe Prelabor Rupture of Membranes PROM Rapid Tests Sales by Country (Units), 2027–2032
Table 34. Europe Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Country (US$ Million), 2021–2026
Table 35. Europe Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Country (US$ Million), 2027–2032
Table 36. Asia Pacific Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 37. Asia Pacific Prelabor Rupture of Membranes PROM Rapid Tests Sales by Region (Units), 2021–2026
Table 38. Asia Pacific Prelabor Rupture of Membranes PROM Rapid Tests Sales by Region (Units), 2027–2032
Table 39. Asia Pacific Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Region (US$ Million), 2021–2026
Table 40. Asia Pacific Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Region (US$ Million), 2027–2032
Table 41. Latin America Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 42. Latin America Prelabor Rupture of Membranes PROM Rapid Tests Sales by Country (Units), 2021–2026
Table 43. Latin America Prelabor Rupture of Membranes PROM Rapid Tests Sales by Country (Units), 2027–2032
Table 44. Latin America Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Country (US$ Million), 2021–2026
Table 45. Latin America Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Country (US$ Million), 2027–2032
Table 46. Middle East and Africa Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 47. Middle East and Africa Prelabor Rupture of Membranes PROM Rapid Tests Sales by Country (Units), 2021–2026
Table 48. Middle East and Africa Prelabor Rupture of Membranes PROM Rapid Tests Sales by Country (Units), 2027–2032
Table 49. Middle East and Africa Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Country (US$ Million), 2021–2026
Table 50. Middle East and Africa Prelabor Rupture of Membranes PROM Rapid Tests Revenue by Country (US$ Million), 2027–2032
Table 51. Global Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units) by Type (2021–2026)
Table 52. Global Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units) by Type (2027–2032)
Table 53. Global Prelabor Rupture of Membranes PROM Rapid Tests Sales Market Share by Type (2021–2026)
Table 54. Global Prelabor Rupture of Membranes PROM Rapid Tests Sales Market Share by Type (2027–2032)
Table 55. Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue (US$ Million) by Type (2021–2026)
Table 56. Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue (US$ Million) by Type (2027–2032)
Table 57. Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue Market Share by Type (2021–2026)
Table 58. Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue Market Share by Type (2027–2032)
Table 59. Global Prelabor Rupture of Membranes PROM Rapid Tests Price (US$/Unit) by Type (2021–2026)
Table 60. Global Prelabor Rupture of Membranes PROM Rapid Tests Price (US$/Unit) by Type (2027–2032)
Table 61. Global Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units) by Application (2021–2026)
Table 62. Global Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units) by Application (2027–2032)
Table 63. Global Prelabor Rupture of Membranes PROM Rapid Tests Sales Market Share by Application (2021–2026)
Table 64. Global Prelabor Rupture of Membranes PROM Rapid Tests Sales Market Share by Application (2027–2032)
Table 65. Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue (US$ Million) by Application (2021–2026)
Table 66. Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue (US$ Million) by Application (2027–2032)
Table 67. Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue Market Share by Application (2021–2026)
Table 68. Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue Market Share by Application (2027–2032)
Table 69. Global Prelabor Rupture of Membranes PROM Rapid Tests Price (US$/Unit) by Application (2021–2026)
Table 70. Global Prelabor Rupture of Membranes PROM Rapid Tests Price (US$/Unit) by Application (2027–2032)
Table 71. QIAGEN Sciences LLC Company Information
Table 72. QIAGEN Sciences LLC Description and Business Overview
Table 73. QIAGEN Sciences LLC Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 74. QIAGEN Sciences LLC Prelabor Rupture of Membranes PROM Rapid Tests Product
Table 75. QIAGEN Sciences LLC Recent Developments/Updates
Table 76. Clinical Innovations, LLC Company Information
Table 77. Clinical Innovations, LLC Description and Business Overview
Table 78. Clinical Innovations, LLC Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 79. Clinical Innovations, LLC Prelabor Rupture of Membranes PROM Rapid Tests Product
Table 80. Clinical Innovations, LLC Recent Developments/Updates
Table 81. Actim Oy Company Information
Table 82. Actim Oy Description and Business Overview
Table 83. Actim Oy Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 84. Actim Oy Prelabor Rupture of Membranes PROM Rapid Tests Product
Table 85. Actim Oy Recent Developments/Updates
Table 86. BIOSYNEX SA Company Information
Table 87. BIOSYNEX SA Description and Business Overview
Table 88. BIOSYNEX SA Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 89. BIOSYNEX SA Prelabor Rupture of Membranes PROM Rapid Tests Product
Table 90. BIOSYNEX SA Recent Developments/Updates
Table 91. TODA PHARMA Company Information
Table 92. TODA PHARMA Description and Business Overview
Table 93. TODA PHARMA Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 94. TODA PHARMA Prelabor Rupture of Membranes PROM Rapid Tests Product
Table 95. TODA PHARMA Recent Developments/Updates
Table 96. Vitrosens Biotechnology Company Information
Table 97. Vitrosens Biotechnology Description and Business Overview
Table 98. Vitrosens Biotechnology Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 99. Vitrosens Biotechnology Prelabor Rupture of Membranes PROM Rapid Tests Product
Table 100. Vitrosens Biotechnology Recent Developments/Updates
Table 101. Hangzhou AllTest Biotech Co., Ltd. Company Information
Table 102. Hangzhou AllTest Biotech Co., Ltd. Description and Business Overview
Table 103. Hangzhou AllTest Biotech Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 104. Hangzhou AllTest Biotech Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Product
Table 105. Hangzhou AllTest Biotech Co., Ltd. Recent Developments/Updates
Table 106. Zhejiang Orient Gene Biotech Co., Ltd. Company Information
Table 107. Zhejiang Orient Gene Biotech Co., Ltd. Description and Business Overview
Table 108. Zhejiang Orient Gene Biotech Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 109. Zhejiang Orient Gene Biotech Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Product
Table 110. Zhejiang Orient Gene Biotech Co., Ltd. Recent Developments/Updates
Table 111. Assure Tech Hangzhou Co., Ltd. Company Information
Table 112. Assure Tech Hangzhou Co., Ltd. Description and Business Overview
Table 113. Assure Tech Hangzhou Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 114. Assure Tech Hangzhou Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Product
Table 115. Assure Tech Hangzhou Co., Ltd. Recent Developments/Updates
Table 116. Hangzhou Biotest Biotech Co., Ltd. Company Information
Table 117. Hangzhou Biotest Biotech Co., Ltd. Description and Business Overview
Table 118. Hangzhou Biotest Biotech Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 119. Hangzhou Biotest Biotech Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Product
Table 120. Hangzhou Biotest Biotech Co., Ltd. Recent Developments/Updates
Table 121. Jiangsu Bioperfectus Technologies Co., Ltd. Company Information
Table 122. Jiangsu Bioperfectus Technologies Co., Ltd. Description and Business Overview
Table 123. Jiangsu Bioperfectus Technologies Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 124. Jiangsu Bioperfectus Technologies Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Product
Table 125. Jiangsu Bioperfectus Technologies Co., Ltd. Recent Developments/Updates
Table 126. Wuhan EasyDiagnosis Biomedicine Co., Ltd. Company Information
Table 127. Wuhan EasyDiagnosis Biomedicine Co., Ltd. Description and Business Overview
Table 128. Wuhan EasyDiagnosis Biomedicine Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 129. Wuhan EasyDiagnosis Biomedicine Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Product
Table 130. Wuhan EasyDiagnosis Biomedicine Co., Ltd. Recent Developments/Updates
Table 131. Chengdu VACURE Biotechnology Co., Ltd. Company Information
Table 132. Chengdu VACURE Biotechnology Co., Ltd. Description and Business Overview
Table 133. Chengdu VACURE Biotechnology Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 134. Chengdu VACURE Biotechnology Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Product
Table 135. Chengdu VACURE Biotechnology Co., Ltd. Recent Developments/Updates
Table 136. Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Company Information
Table 137. Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Description and Business Overview
Table 138. Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 139. Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Product
Table 140. Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Recent Developments/Updates
Table 141. Wuxi BioHermes Bio&Medical Technology Co., Ltd. Company Information
Table 142. Wuxi BioHermes Bio&Medical Technology Co., Ltd. Description and Business Overview
Table 143. Wuxi BioHermes Bio&Medical Technology Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 144. Wuxi BioHermes Bio&Medical Technology Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Product
Table 145. Wuxi BioHermes Bio&Medical Technology Co., Ltd. Recent Developments/Updates
Table 146. Zhuhai Encode Medical Engineering Co., Ltd. Company Information
Table 147. Zhuhai Encode Medical Engineering Co., Ltd. Description and Business Overview
Table 148. Zhuhai Encode Medical Engineering Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 149. Zhuhai Encode Medical Engineering Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Product
Table 150. Zhuhai Encode Medical Engineering Co., Ltd. Recent Developments/Updates
Table 151. Hangzhou Testsea Biotechnology Co., Ltd. Company Information
Table 152. Hangzhou Testsea Biotechnology Co., Ltd. Description and Business Overview
Table 153. Hangzhou Testsea Biotechnology Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 154. Hangzhou Testsea Biotechnology Co., Ltd. Prelabor Rupture of Membranes PROM Rapid Tests Product
Table 155. Hangzhou Testsea Biotechnology Co., Ltd. Recent Developments/Updates
Table 156. Key Raw Materials Lists
Table 157. Raw Materials Key Suppliers Lists
Table 158. Prelabor Rupture of Membranes PROM Rapid Tests Distributors List
Table 159. Prelabor Rupture of Membranes PROM Rapid Tests Customers List
Table 160. Prelabor Rupture of Membranes PROM Rapid Tests Market Trends
Table 161. Prelabor Rupture of Membranes PROM Rapid Tests Market Drivers
Table 162. Prelabor Rupture of Membranes PROM Rapid Tests Market Challenges
Table 163. Prelabor Rupture of Membranes PROM Rapid Tests Market Restraints
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
Table 167. Authors List of This Report
List of Figures
Figure 1. Product Picture of Prelabor Rupture of Membranes PROM Rapid Tests
Figure 2. Global Prelabor Rupture of Membranes PROM Rapid Tests Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Prelabor Rupture of Membranes PROM Rapid Tests Market Share by Type: 2025 & 2032
Figure 4. PAMG-1 Tests Product Picture
Figure 5. IGFBP-1 Tests Product Picture
Figure 6. Dual Biomarker Tests Product Picture
Figure 7. Other Product Picture
Figure 8. Global Prelabor Rupture of Membranes PROM Rapid Tests Market Value by Assay Method (US$ Million), 2021–2032
Figure 9. Global Prelabor Rupture of Membranes PROM Rapid Tests Market Share by Assay Method: 2025 vs 2032
Figure 10. Lateral Flow Immunochromatographic Tests Product Picture
Figure 11. Fluorescence Immunoassay Tests Product Picture
Figure 12. Other Product Picture
Figure 13. Global Prelabor Rupture of Membranes PROM Rapid Tests Market Value by Application (US$ Million), 2021–2032
Figure 14. Global Prelabor Rupture of Membranes PROM Rapid Tests Market Share by Application: 2025 & 2032
Figure 15. Preterm PROM Testing
Figure 16. Term PROM Testing
Figure 17. Other
Figure 18. Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 19. Global Prelabor Rupture of Membranes PROM Rapid Tests Market Size (US$ Million), 2021–2032
Figure 20. Global Prelabor Rupture of Membranes PROM Rapid Tests Sales (Units), 2021–2032
Figure 21. Global Prelabor Rupture of Membranes PROM Rapid Tests Average Price (US$/Unit), 2021–2032
Figure 22. Prelabor Rupture of Membranes PROM Rapid Tests Report Years Considered
Figure 23. Prelabor Rupture of Membranes PROM Rapid Tests Sales Share by Manufacturers in 2025
Figure 24. Global Prelabor Rupture of Membranes PROM Rapid Tests Revenue Share by Manufacturers in 2025
Figure 25. Top 5 and Top 10 Global Prelabor Rupture of Membranes PROM Rapid Tests Players: Market Share by Revenue in Prelabor Rupture of Membranes PROM Rapid Tests in 2025
Figure 26. Prelabor Rupture of Membranes PROM Rapid Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 27. Global Prelabor Rupture of Membranes PROM Rapid Tests Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 28. North America Prelabor Rupture of Membranes PROM Rapid Tests Sales Market Share by Country (2021–2032)
Figure 29. North America Prelabor Rupture of Membranes PROM Rapid Tests Revenue Market Share by Country (2021–2032)
Figure 30. United States Prelabor Rupture of Membranes PROM Rapid Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Canada Prelabor Rupture of Membranes PROM Rapid Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Europe Prelabor Rupture of Membranes PROM Rapid Tests Sales Market Share by Country (2021–2032)
Figure 33. Europe Prelabor Rupture of Membranes PROM Rapid Tests Revenue Market Share by Country (2021–2032)
Figure 34. Germany Prelabor Rupture of Membranes PROM Rapid Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. France Prelabor Rupture of Membranes PROM Rapid Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. U.K. Prelabor Rupture of Membranes PROM Rapid Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Italy Prelabor Rupture of Membranes PROM Rapid Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Russia Prelabor Rupture of Membranes PROM Rapid Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Asia Pacific Prelabor Rupture of Membranes PROM Rapid Tests Sales Market Share by Region (2021–2032)
Figure 40. Asia Pacific Prelabor Rupture of Membranes PROM Rapid Tests Revenue Market Share by Region (2021–2032)
Figure 41. China Prelabor Rupture of Membranes PROM Rapid Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Japan Prelabor Rupture of Membranes PROM Rapid Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. South Korea Prelabor Rupture of Membranes PROM Rapid Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. India Prelabor Rupture of Membranes PROM Rapid Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Australia Prelabor Rupture of Membranes PROM Rapid Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. China Taiwan Prelabor Rupture of Membranes PROM Rapid Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Southeast Asia Prelabor Rupture of Membranes PROM Rapid Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Latin America Prelabor Rupture of Membranes PROM Rapid Tests Sales Market Share by Country (2021–2032)
Figure 49. Latin America Prelabor Rupture of Membranes PROM Rapid Tests Revenue Market Share by Country (2021–2032)
Figure 50. Mexico Prelabor Rupture of Membranes PROM Rapid Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Brazil Prelabor Rupture of Membranes PROM Rapid Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Argentina Prelabor Rupture of Membranes PROM Rapid Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Colombia Prelabor Rupture of Membranes PROM Rapid Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Middle East and Africa Prelabor Rupture of Membranes PROM Rapid Tests Sales Market Share by Country (2021–2032)
Figure 55. Middle East and Africa Prelabor Rupture of Membranes PROM Rapid Tests Revenue Market Share by Country (2021–2032)
Figure 56. Turkey Prelabor Rupture of Membranes PROM Rapid Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. Saudi Arabia Prelabor Rupture of Membranes PROM Rapid Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. UAE Prelabor Rupture of Membranes PROM Rapid Tests Revenue Growth Rate (US$ Million), 2021–2032
Figure 59. Global Sales Market Share of Prelabor Rupture of Membranes PROM Rapid Tests by Type (2021–2032)
Figure 60. Global Revenue Market Share of Prelabor Rupture of Membranes PROM Rapid Tests by Type (2021–2032)
Figure 61. Global Prelabor Rupture of Membranes PROM Rapid Tests Price (US$/Unit) by Type (2021–2032)
Figure 62. Global Sales Market Share of Prelabor Rupture of Membranes PROM Rapid Tests by Application (2021–2032)
Figure 63. Global Revenue Market Share of Prelabor Rupture of Membranes PROM Rapid Tests by Application (2021–2032)
Figure 64. Global Prelabor Rupture of Membranes PROM Rapid Tests Price (US$/Unit) by Application (2021–2032)
Figure 65. Prelabor Rupture of Membranes PROM Rapid Tests Value Chain
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Physical Graphing Calculators Market Research Report 2026
Nov 14, 26
Global Graphics Calculators Market Research Report 2026
Nov 14, 26
Global Internet and Wi-fi Connected Smart Dishwashers Market Research Report 2026
Nov 14, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232